News - North America

Filter

Current filters:

North America

Popular Filters

1810 to 1834 of 1895 results

US FDA approves Bristol-Myers Squibb’s Nulojix for kidney transplant patients

16-06-2011

In a much anticipated move following a positive 13 to five advisory committee vote (The Pharma Letter…

belataceptBristol-Myers SquibbImmunologicalsNorth AmericaNulojixPharmaceuticalRegulation

Bladder cancer risk of Takeda’s Actos now highlighted by US FDA

16-06-2011

The latest bad news for Japan’s largest drugmaker, Takeda Pharmaceutical (TYO: 4502) came last night…

ActosDiabetesNorth AmericaPharmaceuticalRegulationTakeda Pharmaceuticals

Boehringer Ingelheim and Lilly begin US roll-out of diabetes drug Tradjenta

16-06-2011

German independent drug major Boehringer Ingelheim and USA-based Eli Lilly (NYSE: LLY) announced yesterday…

Boehringer IngelheimDiabetesEli LillyMarkets & MarketingNorth AmericaPharmaceuticalTradjenta

US generics group GPhA voices worries on TPP agreement negotiations

15-06-2011

The USA’s Generic Pharmaceutical Association (GPhA) says that it has sent a letter to President…

BiotechnologyGenericsMarkets & MarketingNorth AmericaPatents

Dr Reddy’s warned by US FDA over API facility in Mexico

15-06-2011

Indian generic drug major Dr Reddy’s Laboratories (NYSE:RDY) revealed yesterday that its wholly-owned…

Dr Reddy's LaboratoriesGenericsNorth AmericaRegulationSouth America

US pharma has 277 medicines in development for skin diseases

15-06-2011

The USA’s biopharmaceutical research companies currently are developing 277 medicines to help the…

DermatologicalsNorth AmericaPharmaceuticalResearch

Abbott Labs sued over debilitating side effect with Humira

14-06-2011

A law suit has been filed against US health care major Abbott Laboratories (NYSE: ABT) in a US federal…

Abbott LaboratoriesAnti-Arthritics/RheumaticsHumiraLegalNorth AmericaPharmaceutical

US FDA warns on risk of more serious forms of prostate cancer with 5-ARI drugs

13-06-2011

The US Food and Drug Administration has warned that the labeling for drugs used to treat enlarged prostate…

AvodartGlaxoSmithKlineMerck & CoNorth AmericaOncologyPharmaceuticalProscarRegulation

Gilead Sciences subpoenaed in USA over HIV and other drugs

13-06-2011

US biopharmaceutical company Gilead Sciences (Nasdaq: GILD) revealed late Friday that it has received…

Anti-viralsAtriplaBiotechnologyGilead SciencesLegalNorth AmericaPharmaceuticalTruvada

GlaxoSmithKline and Valeant get FDA approval for epilepsy drug Potiga

13-06-2011

Following backing from a US Food and Drug Administration advisory panel last summer (The Pharma Letter…

GlaxoSmithKlineNeurologicalNorth AmericaPharmaceuticalPotigaRegulationTrobaltValeant Pharmaceuticals

US FDA working to lessen drug shortage impact

11-06-2011

Last year, the number of drug shortages in the USA reached a record high, and medicine scarcities have…

Markets & MarketingNorth AmericaPharmaceuticalRegulation

Pfizer to invest $100 million in Boston area academia for therapeutic innovation

10-06-2011

New York-based Pfizer (NYSE: PFE), the world’s largest drugmaker by sales, says its network of translational…

FinancialNorth AmericaPfizerPharmaceuticalResearch

Judge vacates Amylin injunction against Eli Lilly; latter updates Humalog label

09-06-2011

It was a good news day for US drug major Eli Lilly (NYSE: LLY) yesterday, as the firm received approval…

AmylinBoehringer IngelheimDiabetesEli LillyExenatide InjectionHumalogLegallinagliptinNorth AmericaPharmaceuticalRegulation

US FDA curbs use of high-dose simvastatin, citing increased risk of muscle injury

09-06-2011

The US Food and Drug Administration yesterday announced safety label changes for the cholesterol-lowering…

Abbott LaboratoriesCardio-vascularMerck & CoNorth AmericaPharmaceuticalRegulationSimcorSimvastatinZocor

CETA with EU would wipe out Canada’s drug savings, says generic drugmakers, but Rx& D sees benefits

09-06-2011

The European Union is in negotiations for a comprehensive economic and trade agreement (CETA) with Canada.…

EuropeGenericsMarkets & MarketingNorth AmericaPatentsPharmaceuticalPolitics

Changing of the Guard begins in biotech sector

08-06-2011

The biotechnology sector is bracing for change this year as a flurry of "biosimilar" or "biogeneric"…

BiotechnologyGenericsMarkets & MarketingNorth AmericaRegulation

Battle for share of US $8.5 billion in vitro diagnostic market

08-06-2011

The US in-vitro diagnostic market, including immunochemistry, molecular diagnostics, point-of-care testing,…

Abbott LaboratoriesMarkets & MarketingNorth AmericaPharmaceuticalRoche

FDA accepts ciclesonide NDA from Nycomed partner Sunovion

07-06-2011

Swiss drugmaker Nycomed, the subject of a $13.7 billion takeover bid from Japan’s Takeda (TYO:4502;…

Ciclesonide Inhalation AerosolNorth AmericaNycomedPharmaceuticalRegulationRespiratory and PulmonarySunovion

Blow for Orexigen as regulatory demands see firm put obesity drug Contrave on hold

06-06-2011

Shares of US biotech firm Orexigen Therapeutics (Nasdaq: OREX) plunged 33% to $2.13 by afternoon trading…

ContraveMetabolicsNorth AmericaOrexigen TherapeuticsPharmaceuticalRegulation

Johnson & Johnson faces $327 million penalty over Risperdal marketing

06-06-2011

Civil penalties amounting to just over $327 million have been announced in the case of State of South…

Johnson & JohnsonLegalNeurologicalNorth AmericaOrtho-McNeil-JanssenPharmaceuticalRisperdal

US Biotech posts small gain in May, says Burrill

06-06-2011

It was a quiet month for US biotech with the Burrill Biotech Select Index recording a small 2.8% gain…

BiotechnologyFinancialNorth America

1810 to 1834 of 1895 results

Company Spotlight

Fibrotech

Fibrotech

Back to top